{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:43:27Z","timestamp":1790603007606,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-109023140B0002-156"],"award-info":[{"award-number":["MOST-109023140B0002-156"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jfma.2020.10.026","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T09:04:06Z","timestamp":1605603846000},"page":"1061-1068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Outcomes and prognostic factors associated with 180-day mortality in Taiwanese pediatric patients with Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-0074","authenticated-orcid":false,"given":"Teng-Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Tsamn","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiann-Tarng","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.10.026_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH","volume":"161","author":"Usmani","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib2","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2020.10.026_bib3","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1097\/MPH.0000000000000073","article-title":"Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma","volume":"36","author":"Ciambotti","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfma.2020.10.026_bib4","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2020.10.026_bib5","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2020.10.026_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.jfma.2020.10.026_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2019.00395","article-title":"Pathogenic gene mutations or variants identified by targeted gene sequencing in adults with hemophagocytic lymphohistiocytosis","volume":"10","author":"Miao","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jfma.2020.10.026_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2020.10.026_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cge.13363","article-title":"Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP","volume":"94","author":"Chen","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.jfma.2020.10.026_bib10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12185-017-2223-3","article-title":"Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis","volume":"106","author":"Mukda","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib11","article-title":"Hemophagocytic lymphohistocytosis in the Chinese han population may Be associated with an STXBP2 gene polymorphism","volume":"11","author":"Yang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2020.10.026_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfma.2020.10.026_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13073-015-0244-1","article-title":"Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis","volume":"7","author":"Tesi","year":"2015","journal-title":"Genome Med"},{"key":"10.1016\/j.jfma.2020.10.026_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/ejh.12399","article-title":"Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party","volume":"94","author":"Koh","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3324\/haematol.2009.016949","article-title":"UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis","volume":"9b5","author":"Yoon","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jfma.2020.10.026_bib16","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2020.10.026_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12887-020-02178-7","article-title":"Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children","volume":"20","author":"Pan","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jfma.2020.10.026_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/16078454.2019.1660458","article-title":"Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients","volume":"24","author":"Zhao","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.jfma.2020.10.026_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cyto.2017.03.013","article-title":"Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis","volume":"97","author":"Luo","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jfma.2020.10.026_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00277-016-2727-6","article-title":"Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases","volume":"95","author":"Bin","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.jfma.2020.10.026_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26264","article-title":"Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: a retrospective multicenter study","volume":"64","author":"Xu","year":"2017","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.jfma.2020.10.026_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-018-02572-z","article-title":"Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan","volume":"109","author":"Yanagisawa","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jfma.2020.10.026_bib25","first-page":"193","article-title":"Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: a report from the Taiwan Pediatric Oncology Group (TPOG)","volume":"41","author":"Yang","year":"2000","journal-title":"Acta Paediatr Taiwanica"},{"key":"10.1016\/j.jfma.2020.10.026_bib26","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2020.10.026_bib27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group","volume":"61","author":"Kogawa","year":"2014","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.jfma.2020.10.026_bib28","first-page":"1869","article-title":"Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy","volume":"93","author":"Imashuku","year":"1999","journal-title":"Histiocyte Soc Blood"},{"key":"10.1016\/j.jfma.2020.10.026_bib29","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2020.10.026_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0609.1997.tb00984.x","article-title":"Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases","volume":"59","author":"Kaito","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfma.2020.10.026_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.1989.tb00302.x","article-title":"Pure red cell aplasia in association with virus associated haemophagocytic syndrome (VAHS)","volume":"73","author":"Hanada","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jfma.2020.10.026_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2169\/internalmedicine.48.1677","article-title":"Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome","volume":"48","author":"Okamoto","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jfma.2020.10.026_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1651-2227.1991.tb11928.x","article-title":"Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jfma.2020.10.026_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/cyto.1996.0071","article-title":"Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines","volume":"8","author":"Tengku-Muhammad","year":"1996","journal-title":"Cytokine"},{"key":"10.1016\/j.jfma.2020.10.026_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-9-5","article-title":"Impaired plasma lipid profiles in acute hepatitis","volume":"9","author":"Luo","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jfma.2020.10.026_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jfma.2020.03.025","article-title":"Outcome analysis of pediatric hemophagocytic lymphohistiocytosis","volume":"120","author":"Chen","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.10.026_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08880018.2019.1572253","article-title":"Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis","volume":"36","author":"Oguz","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfma.2020.10.026_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1651-2227.2011.02501.x","article-title":"Risk factors for early death in children with haemophagocytic lymphohistiocytosis","volume":"101","author":"Trottestam","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jfma.2020.10.026_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08880018.2013.858198","article-title":"Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): a single-institution case-series in Vietnam","volume":"31","author":"Dao","year":"2014","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620305246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620305246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:43:45Z","timestamp":1760539425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620305246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0929664620305246"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.10.026","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and prognostic factors associated with 180-day mortality in Taiwanese pediatric patients with Hemophagocytic Lymphohistiocytosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}